Acute perioperative heart failure

Current Opinion in Anaesthesiology
Wolfgang G Toller, Helfried Metzler

Abstract

Changes in epidemiology and advances in the treatment of coronary artery disease, hypertension and diabetes mellitus have increased the prevalence of heart failure in the general population, and also the number of patients with heart failure presenting for surgery. Particularly in the perioperative period, patients with chronic heart failure are faced with numerous triggers of acute decompensation that can partly be avoided or treated. Patients without preexisting myocardial contractile dysfunction may sustain severe perioperative complications, e.g. myocardial infarction, with subsequent acute heart failure as a consequence. Approaches for diagnosis and treatment in these situations may vary considerably. Patients with preexisting heart failure undergoing non-cardiac surgery suffer substantial morbidity and mortality despite advances in perioperative care. The importance of heart failure as an independent risk factor is underlined by the fact that patients with coronary artery disease but without heart failure have a similar 30-day mortality rate to the general population. B-type natriuretic peptide testing is an attractive and non-invasive tool in non-surgical patients for the diagnosis of heart failure, but its role in the p...Continue Reading

References

Mar 9, 1996·Lancet·D Northridge
Apr 15, 1999·The New England Journal of Medicine·R J GoldbergJ M Gore
Feb 15, 2001·JAMA : the Journal of the American Medical Association·J S HochmanUNKNOWN SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock
Jan 17, 2002·The New England Journal of Medicine·G van den BergheR Bouillon
Feb 9, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Sharon A HuntUNKNOWN American Heart Association
Mar 28, 2002·JAMA : the Journal of the American Medical Association·Michael S CuffeUNKNOWN Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigato
Jul 23, 2002·Lancet·F FollathUNKNOWN Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study
Nov 1, 2002·The New England Journal of Medicine·Daniel LevyRamachandran S Vasan
Dec 18, 2002·American Heart Journal·Andrew J BurgerUNKNOWN Prospective Randomized Evaluation of Cardiac Ectopy with Dobutamine or Natrecor Therapy
Feb 18, 2003·Current Opinion in Clinical Nutrition and Metabolic Care·Mette M Berger, Iqbal Mustafa
Mar 4, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Peter A McCulloughUNKNOWN Breathing Not Properly Multinational Study Investigators
Mar 26, 2003·Journal of the American College of Cardiology·G Michael FelkerUNKNOWN OPTIME-CHF Investigators
Apr 23, 2003·Journal of the American College of Cardiology·Alice K JacobsJudith S Hochman
May 27, 2003·Heart Failure Reviews·Antonio VitarelliMihai Gheorghiade
May 28, 2003·Journal of the American College of Cardiology·Anju NohriaLynne W Stevenson
Jun 12, 2003·Journal of the American College of Cardiology·Alan S MaiselUNKNOWN Breathing Not Properly Multinational Study Investigators
Nov 8, 2003·Chest·Noelle LimJean-Louis Vincent
Nov 18, 2003·Intensive Care Medicine·Alexandre MebazaaLars Algotsson
Nov 25, 2003·Journal of Interventional Cardiology·Michael P SiegenthalerFriedhelm Beyersdorf
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Chaim YosefyShimon Scharf
Jan 20, 2004·Journal of Perianesthesia Nursing : Official Journal of the American Society of PeriAnesthesia Nurses·Alice Johnson-Davis
Feb 13, 2004·The New England Journal of Medicine·Christian MuellerAndré P Perruchoud
Feb 26, 2004·Anesthesia and Analgesia·Sidney BenloloAlexandre Mebazaa
Mar 6, 2004·The Journal of Thoracic and Cardiovascular Surgery·M P SiegenthalerF Beyersdorf
Apr 9, 2004·Critical Care Medicine·Dean R ChittockJohn C Fenwick
Apr 16, 2004·Journal of Cardiovascular Pharmacology·Petri KaheinenHeimo Haikala
May 6, 2004·International Journal of Clinical Pharmacology and Therapeutics·C LabriolaB Amantea
Jun 12, 2004·The Thoracic and Cardiovascular Surgeon·D H L BailG Ziemer
Jun 18, 2004·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Jan-Peter BraunJianshi Liu
Jul 21, 2004·The Heart Surgery Forum·John W C EntwistleKourosh Baghelai
Aug 3, 2004·Critical Care Medicine·Roderick H TungJames L Januzzi

❮ Previous
Next ❯

Citations

May 16, 2006·Critical Care : the Official Journal of the Critical Care Forum·Suzana M LoboGeni S Cunrath
Apr 16, 2011·Journal of Cardiothoracic and Vascular Anesthesia·Solomon Aronson, Joseph Varon
Dec 18, 2007·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Hiroyasu BitohAtsuhiro Sakamoto
Apr 22, 2015·Revista brasileira de anestesiologia·Fabiola Quinteros HinojosaFernando Gilsanz
Aug 16, 2016·International Journal of Surgery Case Reports·Moana Rossella NespoliSalvatore Buono
Sep 20, 2007·Journal of Cardiovascular Pharmacology·Piero Pollesello, Zoltán Papp

❮ Previous
Next ❯

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.